An in-competition failure for a recreational drug has netted UFC welterweight Brad Scott a two-year suspension, the U.S. Anti-Doping Agency (USADA) announced today.

According to a press release, Scott (11-6 MMA, 3-5 UFC) failed an in-competition test for benzoylecgonine – a metabolite of cocaine – after his loss to Carlo Pedersoli Jr. (11-1 MMA, 1-0 UFC) at UFC Fight Night 130, which took place May 27 in Liverpool, England.

Cocaine is classified as a non-specified substance in the class of stimulants under the UFC’s anti-doping program and is banned in-competition. First-time offenders face a two-year sanction.

In 2015, prior to the UFC anti-doping program’s existence, ex-champ Jon Jones avoided punishment when he was mistakenly tested out-of-competition for the drug and came up positive.

In Scott’s case, USADA determined the 29-year-old fighter “had not provided verifiable evidence regarding the circumstances that led to his positive test.”

Scott’s suspension is retroactive to July 3, the date he was provisionally suspended following notification of a potential anti-doping violation. Per the terms of his suspension, he will need to make himself available to random testing as part of the USADA testing pool.

Scott is 3-4 in the octagon since coming up short in the finals of “The Ultimate Fighter: Smashes.” His loss to Pedersoli Jr. was his first UFC bout at welterweight and left him at 1-3 in his past four outings.

For complete coverage of UFC Fight Night 130, check out the UFC Events section of the site.